Hugel, Inc. (KOSDAQ:145020)
South Korea · Delayed Price · Currency is KRW 270,000
+4,500 (1.69%)
At close: Feb 27, 2026
Hugel Market Cap
Hugel has a market cap or net worth of 2.92 trillion as of February 27, 2026. Its market cap has increased by 12.93% in one year.
Market Cap
2.92T
Enterprise Value
2.50T
Revenue
425.10B
Ranking
n/a
PE Ratio
21.13
Stock Price
270,000.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 2.92T, an increase of 427.65%. That is a compound annual growth rate of 17.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.92T | 17.14% |
| Dec 30, 2025 | 2.49T | -19.40% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 6.90T |
| LigaChem Biosciences | 6.71T |
| Peptron | 6.68T |
| Voronoi | 5.64T |
| SK bioscience | 3.96T |
| D&D Pharmatech | 3.87T |
| PharmaResearch | 3.63T |
| OliX Pharmaceuticals | 3.22T |